Barclays PLC grew its holdings in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) by 56.1% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 678,397 shares of the real estate investment trust's stock after buying an additional 243,895 shares during the quarter. Barclays PLC owned 0.29% of Sabra Health Care REIT worth $12,624,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Family Firm Inc. acquired a new position in Sabra Health Care REIT during the 2nd quarter valued at about $26,000. Quarry LP bought a new position in shares of Sabra Health Care REIT in the third quarter valued at approximately $30,000. Assetmark Inc. boosted its position in shares of Sabra Health Care REIT by 168.4% during the third quarter. Assetmark Inc. now owns 1,962 shares of the real estate investment trust's stock valued at $37,000 after buying an additional 1,231 shares during the last quarter. Harbor Capital Advisors Inc. bought a new stake in Sabra Health Care REIT during the third quarter worth $78,000. Finally, GAMMA Investing LLC raised its position in Sabra Health Care REIT by 25.3% in the 3rd quarter. GAMMA Investing LLC now owns 4,614 shares of the real estate investment trust's stock valued at $86,000 after buying an additional 932 shares during the last quarter. 99.40% of the stock is owned by institutional investors.
A number of equities analysts have issued reports on the stock. Scotiabank lifted their price objective on shares of Sabra Health Care REIT from $17.00 to $18.00 and gave the stock a "sector perform" rating in a report on Friday, October 11th. Wells Fargo & Company upgraded shares of Sabra Health Care REIT from an "equal weight" rating to an "overweight" rating and boosted their price target for the stock from $16.00 to $20.00 in a report on Tuesday, October 1st. Mizuho reiterated a "neutral" rating and issued a $20.00 price objective on shares of Sabra Health Care REIT in a research note on Thursday, December 5th. Citigroup upgraded Sabra Health Care REIT from a "neutral" rating to a "buy" rating and boosted their target price for the stock from $17.00 to $20.00 in a research note on Friday, September 13th. Finally, Truist Financial increased their price target on Sabra Health Care REIT from $16.00 to $18.00 and gave the company a "buy" rating in a research report on Wednesday, September 4th. Two analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $19.14.
Check Out Our Latest Report on Sabra Health Care REIT
Shares of NASDAQ SBRA opened at $17.50 on Monday. The company has a current ratio of 4.16, a quick ratio of 4.16 and a debt-to-equity ratio of 0.90. The stock has a fifty day simple moving average of $18.52 and a two-hundred day simple moving average of $17.11. Sabra Health Care REIT, Inc. has a 1-year low of $12.83 and a 1-year high of $20.03. The firm has a market cap of $4.14 billion, a price-to-earnings ratio of 42.68, a price-to-earnings-growth ratio of 2.20 and a beta of 1.24.
Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last posted its quarterly earnings results on Thursday, October 31st. The real estate investment trust reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.35 by ($0.22). Sabra Health Care REIT had a return on equity of 3.51% and a net margin of 14.20%. The firm had revenue of $178.00 million for the quarter, compared to the consensus estimate of $177.19 million. During the same quarter in the previous year, the company posted $0.34 EPS. Analysts anticipate that Sabra Health Care REIT, Inc. will post 1.39 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which was paid on Friday, November 29th. Stockholders of record on Friday, November 15th were given a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 6.86%. The ex-dividend date was Friday, November 15th. Sabra Health Care REIT's dividend payout ratio (DPR) is currently 292.69%.
As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing - Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Sabra Health Care REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Health Care REIT wasn't on the list.
While Sabra Health Care REIT currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.